Gestational diabetes mellitus and neonatal hyperthyrotropinemia

Area of Science:

• Neonatal endocrinology
• Maternal-fetal medicine
• Endocrinology

Background:

• Gestational diabetes mellitus (GDM) affects maternal and fetal health.
• Neonatal hyperthyrotropinemia is a condition characterized by elevated TSH levels in newborns.
• Understanding the link between GDM and neonatal outcomes is crucial for clinical practice.

Purpose of the Study:

• To investigate the association between gestational diabetes mellitus (GDM) and the incidence of neonatal hyperthyrotropinemia.
• To compare cord blood TSH concentrations in infants born to mothers with and without GDM.

Main Methods:

• A retrospective study compared 469 GDM pregnancies with 474 non-diabetic pregnancies.
• Maternal characteristics, infant outcomes, and cord blood TSH were analyzed.
• GDM was diagnosed using the World Health Organization 75g oral glucose tolerance test (OGTT).

Main Results:

• Neonatal hyperthyrotropinemia (TSH >16 mIU/l) was significantly more common in GDM pregnancies (7.2%) compared to controls (2.1%).
• TSH levels correlated with OGTT 2-hour glucose values and fifth-minute Apgar scores in GDM pregnancies.
• Hyperthyrotropinemic newborns in the GDM group had a higher incidence of neonatal jaundice.

Conclusions:

• Gestational diabetes mellitus is associated with a higher frequency of neonatal hyperthyrotropinemia.
• This increased incidence may indicate heightened fetal hypoxic stress during pregnancy in women with GDM.
• Further research is warranted to explore the mechanisms and clinical implications.